Beijing Centergate Technologies (holding) Co., Ltd. (SZSE: 000931)
Real Estate · Real Estate Management & Development · CN
CN¥5.09
+18.37% today · -9.3% 1Y
Beijing Centergate Technologies (holding) Co., Ltd. (SZSE: 000931) operates in the Real Estate Management & Development industry within the Real Estate sector. The company is valued at $570.25M and employs 2,267 people.
Over the last twelve months the share price has lost 9.3%, trading between 3.76 and 5.73.
Tweenvest scores Beijing Centergate Technologies (holding) Co., Ltd. across four factors: quality 59/100, value 42/100, growth 38/100, dividend 10/100. Its strongest factor is quality.
000931 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $570.25M
- Revenue (TTM)
- $325.58M
- P/E
- —
- EPS
- -0.03
- Dividend yield
- 0.39%
- Beta (5Y)
- 0.27
- 52-week high
- CN¥5.73
- 52-week low
- CN¥3.76
- Avg volume (3M)
- —
- Shares outstanding
- 753.13M
- Employees
- 2,267
- Next earnings
- —
About Beijing Centergate Technologies (holding) Co., Ltd.
Beijing Centergate Technologies (holding) Co., Ltd. is a multifaceted corporation with a presence in both domestic Chinese and international markets. Its principal activities include the manufacturing and distribution of pharmaceuticals, undertaking construction projects, developing real estate, and providing property management services. The company's pharmaceutical division offers a diverse range of medicinal products, such as huasu west-ground iodine, fesser phenylcycline hydrochloride, bosu fuma acid bisolol, yuanji beni flat hydrochloric acid, and naloxone hydrochloride, along with various tablets and capsules like five plus biochemical and aramol quramado. In addition to traditional medicines, Beijing Centergate Technologies produces specialized oral and mucous membrane repair and health products, encompassing toothpaste, mouthwash, sprays, and dental equipment. These items are designed to address issues like ulcers, burns, mechanical damage, and support post-operative healing. Furthermore, the company supplies nutritional products and food-grade raw materials, including fruit enzymes, imported fungella enzymes, beneficial probiotics, and soda. Beyond its operational segments, the firm also allocates investments to high-tech sectors such as software, communications and electronic engineering, biomedicine, and other areas within the life sciences. Established in Beijing, China, in 1999, the company remains headquartered in its founding city.
- ISIN
- CNE000001030
- Founded
- 1999
- Listed since
- Jul 12, 1999
- Exchange
- Shenzhen Stock Exchange
- Currency
- CNY
Other Real Estate Management & Development companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Vingroup Joint Stock CompanyHOSE: VIC | $58.86B | ₫205,000.00 | +1.49% |
| Sun Hung Kai Properties LimitedSEHK: 16 | $47.38B | HK$128.20 | +2.81% |
| CBRE Group, Inc.NYSE: CBRE | $44.04B | $152.10 | +0.20% |
| China Resources Land LimitedSEHK: 1109 | $32.18B | HK$35.38 | +0.40% |
| Mitsubishi Estate Co., Ltd.TSE: 8802 | $27.90B | ¥3,687.00 | +0.19% |
| Emaar Properties PJSCDFM: EMAAR | $26.37B | AED10.96 | -0.90% |
| Mitsui Fudosan Co., Ltd.TSE: 8801 | $25.36B | ¥1,498.00 | +0.54% |
| Vinhomes Joint Stock CompanyHOSE: VHM | $22.55B | ₫71,700.00 | +3.17% |
Figures last refreshed Aug 18, 2026.